Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Eiko Lifesciences Ltd (EIKO) Share Price & Fundamentals

Company Overview

Founded Year

1977

Listed Year

2016

Headquarter

Thane, Maharashtra, India

MD/CEO

Laxmikant Kabra, Chairman with strategic leadership promoting diversification and growth.

Website

https://www.eikolifesciences.com

Company Facts

What we do

Eiko Lifesciences Ltd is a leading Indian manufacturer, supplier, and exporter of speciality chemicals and pharma intermediates, serving pharmaceutical and agrochemical industries globally.

Founded in

1,977

Market share

One of the fastest growing speciality chemicals companies in India with expanding global footprint.

Problem solved

Provides essential chemical intermediates for pharma and agro industries, addressing quality and supply chain demands.

Top clients or who we serve

Pharmaceutical and agrochemical companies worldwide; B2B business model.

Key management

Laxmikant Kabra, Chairman with strategic leadership promoting diversification and growth.

Our journey and innovations

Founded in 1977, transitioned from share trading to speciality chemical manufacturing in 2020, developed new molecules for agrochemical and pharma sectors in 2022, entered logistics and clinical research in 2025.

Where we operate

Primarily India with exports to global pharmaceutical and agrochemical markets.

Top products or what we offer

Speciality chemicals, pharma intermediates, agrochemical intermediates, logistics container leasing, clinical research services.

Top brands

-

Raw materials needed

Chemical raw materials specific to speciality and fine chemicals production.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily from recurring supply contracts and growing logistics services.

Our industry position

Strong presence in speciality chemical manufacturing with growing diversification into logistics and clinical research.

Financial highlights

FY 2024-25 revenue ₹32.49 crore (+16% YoY), PAT ₹1.74 crore, improving margins driven by volume and diversification.

Geographical revenue split

Revenue mainly from Indian operations with significant exports worldwide.

Order book

-

Whats driving growth

Expansion in speciality chemical products, new molecule launches, logistics and clinical research diversification.

Our future plans

Scale operations, further product innovation, expand logistics container leasing and clinical research domains.

Our green promise

-

Our people and values

Dedicated workforce promoting innovation, compliance and ethical business conduct.

Key challenges ahead

Sustaining growth amid regulatory compliance, raw material cost volatility and market competition.

Interesting facts

Successfully diversified from share trading to speciality chemicals, recently entering container logistics and clinical research sectors.

Risks and strategy

Mitigating risks via robust compliance, diversification, and focus on high-margin speciality chemical products.

Market Footprint

Top Clients

Top Clients

Pharmaceutical and agrochemical companies worldwide; B2B business model.

Top Products

Top Products

Speciality chemicals, pharma intermediates, agrochemical intermediates, logistics container leasing, clinical research services.

Price Movement & Share Holding

Today's High/Low

48.6753

52 Week High/Low

4364.44
Past Returns

1 week

-0.71%

1 month

-6.49%

3 month

-1.97%

1 year

-4.66%

3 year

-16.35%

5 year

-26.59%

Share Holding

Promoters

39.96%

FII

0%

DII

0%

Retail

44.36%

Others

15.68%

Company Overview

Founded Year

1977

Listed Year

2016

Headquarter

Thane, Maharashtra, India

MD/CEO

Laxmikant Kabra

Website

https://www.eikolifesciences.com

Price Movement & Share Holding

Today's High/Low

48.6753

52 Week High/Low

4364.44

Past Returns

1 week

-0.71%

1 month

-6.49%

3 month

-1.97%

1 year

-4.66%

3 year

-16.35%

5 year

-26.59%

Share Holding

Promoters

39.96%

FII

0%

DII

0%

Retail

44.36%

Others

15.68%

Company Facts

What we do

Eiko Lifesciences Ltd is a leading Indian manufacturer, supplier, and exporter of speciality chemicals and pharma intermediates, serving pharmaceutical and agrochemical industries globally.

Founded in

1977

Market share

One of the fastest growing speciality chemicals companies in India with expanding global footprint.

Problem solved

Provides essential chemical intermediates for pharma and agro industries, addressing quality and supply chain demands.

Top clients or who we serve

Pharmaceutical and agrochemical companies worldwide; B2B business model.

Key management

Laxmikant Kabra, Chairman with strategic leadership promoting diversification and growth.

Our journey and innovations

Founded in 1977, transitioned from share trading to speciality chemical manufacturing in 2020, developed new molecules for agrochemical and pharma sectors in 2022, entered logistics and clinical research in 2025.

Where we operate

Primarily India with exports to global pharmaceutical and agrochemical markets.

Top products or what we offer

Speciality chemicals, pharma intermediates, agrochemical intermediates, logistics container leasing, clinical research services.

Raw materials needed

Chemical raw materials specific to speciality and fine chemicals production.

Recurring vs cyclical contribution

Revenue primarily from recurring supply contracts and growing logistics services.

Our industry position

Strong presence in speciality chemical manufacturing with growing diversification into logistics and clinical research.

Financial highlights

FY 2024-25 revenue ₹32.49 crore (+16% YoY), PAT ₹1.74 crore, improving margins driven by volume and diversification.

Geographical revenue split

Revenue mainly from Indian operations with significant exports worldwide.

Whats driving growth

Expansion in speciality chemical products, new molecule launches, logistics and clinical research diversification.

Our future plans

Scale operations, further product innovation, expand logistics container leasing and clinical research domains.

Our people and values

Dedicated workforce promoting innovation, compliance and ethical business conduct.

Key challenges ahead

Sustaining growth amid regulatory compliance, raw material cost volatility and market competition.

Interesting facts

Successfully diversified from share trading to speciality chemicals, recently entering container logistics and clinical research sectors.

Risks and strategy

Mitigating risks via robust compliance, diversification, and focus on high-margin speciality chemical products.

Market Footprint

Top Clients

Top Clients

Pharmaceutical and agrochemical companies worldwide; B2B business model.

Top Products

Top Products

Speciality chemicals, pharma intermediates, agrochemical intermediates, logistics container leasing, clinical research services.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions